http://iupindia.in/810/AN_CRAMS_India_50.html India is a low-cost hub for Contract Research and Manufacturing Services (CRAMS), and with many Big Pharma companies finding it difficult to grow, focus is shifting towards India. Indian CRAMS players enjoying strong relationships with Big Pharma would be the key beneficiaries of the CRO vendor consolidation expected post-restructuring at Big Pharma. 2010 will likely witness a turnaround in the fortunes of Indian CRAMS players.
http://hindi.economictimes.indiatimes.com/articleshow/6319013.cms *ए** **के* * **प्रभाकर**, **स्वतंत्र** **तकनीकी** **विश्लेषक* * * http://akprabhakar.blogspot.com/2010/08/crams-stocks-doing-well.html JUBILANT & GLENMARK we have in FAB15 [image: GLENMARK.JPEG] *Regards* A.K.Prabhakar Equity Analyst [email protected] [email protected] www.akprabhakar.com *Disclaimer:* This represents views based purely on Technical studies. The information and views presented in this report are prepared by A K Prabhakar. The information contained herein is based on my analysis of the Charts and upon sources that I consider reliable. I, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and I am not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither A K Prabhakar nor any person connected with him accepts any liability arising from the use of this information and views mentioned in this document. A K Prabhakar and his affiliates may hold long or short positions in the above-mentioned companies from time to time. The report is intended for a restricted audience and I am not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities. -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
<<image001.jpg>>
